Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
−Removed: Market Information
−Removed: The market in which our common stock is traded is the NASDAQ Global Select Market under the symbol “IRTC”.
−Removed: The following table sets forth the high and low sales price per share of our common stock for each full quarterly period within the two most recent fiscal years as reported on The NASDAQ Global Select Market:
−Removed: High Low High Low
−Removed: First Quarter $ 101.40 $ 57.79 $ 97.34 $ 65.44
−Removed: Second Quarter $ 131.18 $ 72.13 $ 80.48 $ 66.64
−Removed: Third Quarter $ 238.11 $ 111.60 $ 83.77 $ 68.59
−Removed: Fourth Quarter $ 261.17 $ 180.80 $ 72.97 $ 61.00
Holders of Common Stock
8 unchanged sentences
under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.
−Removed: The following graph shows the total stockholder return of an investment of $100 in cash at market close on October 20, 2016 (the first day of trading of our common stock), through December 31, 2020 for (i) our common stock, (ii) the NASDAQ Composite Index (U.S.) and (iii) the NASDAQ Biotechnology Index.
+Added: The following graph shows the total stockholder return of an investment of $100 in cash at market close on December 31, 2016, through December 31, 2021 for (i) our common stock, (ii) the NASDAQ Composite Index (U.S.) and (iii) the NASDAQ Biotechnology Index.
Pursuant to applicable Securities and Exchange Commission rules, all values assume reinvestment of the full amount of all dividends, however no dividends have been declared on our common stock to date.
6 unchanged sentences
Issuer Purchases of Equity Securities
−Removed: Selected Consolidated Financial Data.
−Removed: The information set forth below should be read in conjunction with "Item 7.
−Removed: Management's Discussion and Analysis of Financial Condition and Results of Operations" and our financial statements and related notes included elsewhere in this Annual Report on Form 10-K.
−Removed: The selected consolidated financial data in this section are not intended to replace our financial statements.
−Removed: The statement of operations data for the years ended December 31, 2020, 2019, and 2018, and the balance sheet data at December 31, 2020, and 2019 are derived from our audited consolidated financial statements included elsewhere in this Annual Report on Form 10-K.
−Removed: The statement of operations data for the years ended December 31, 2017 and 2016 and the balance sheet data at December 31, 2018, 2017, and 2016 are derived from our consolidated financial statements, which are not included herein.
−Removed: The financial data included in this report are historical, are not necessarily indicative of results to be expected in any future period, and reflect the revisions which are discussed in Note 1 “Organization and Description of Business” within our consolidated financial statements included in Item 8 of this Annual Report on Form 10-K.
−Removed: Year Ended December 31,
−Removed: (in thousands, except share and per share data)
−Removed: 2020 2019 2018 2017 2016 (1)
−Removed: Consolidated Statements of Operations Data:
−Removed: Revenue $ 265,166 $ 214,552 $ 147,277 $ 99,129 $ 64,551
−Removed: Cost of revenue (2)
−Removed: 70,277 52,485 38,795 28,203 20,891
−Removed: Gross profit 194,889 162,067 108,482 70,926 43,660
−Removed: Operating expenses:
−Removed: Research and development (2)
−Removed: 41,329 37,299 20,860 13,265 7,218
−Removed: Selling, general and administrative (2)
−Removed: 197,233 179,523 133,313 85,252 51,916
−Removed: Total operating expense (2)
−Removed: 238,562 216,822 154,173 98,517 59,134
−Removed: Loss from operations (43,673) (54,755) (45,691) (27,591) (15,474)
−Removed: Interest expense (1,519) (1,643) (3,115) (3,386) (3,248)
−Removed: Other income (expense), net (1)
−Removed: 1,591 1,895 1,501 1,237 (2,073)
−Removed: Loss on extinguishment of debt — — (3,029) — —
−Removed: Loss before income taxes (1)
−Removed: (43,601) (54,503) (50,334) (29,740) (20,795)
−Removed: Income tax provision 229 65 44 — —
−Removed: Net loss $ (43,830) $ (54,568) $ (50,378) $ (29,740) $ (20,795)
−Removed: Net loss per common share, basic and diluted $ (1.58) $ (2.16) $ (2.11) $ (1.31) $ (3.93)
−Removed: Weighted-average shares, basic and diluted 27,754,404 25,265,918 23,885,858 22,627,327 5,285,847
−Removed: (1) As disclosed in Note 1 to our consolidated financial statements included within this Annual Report on Form 10-K, we revised certain prior period financial information for immaterial errors in our accounting for revenues, contractual allowances, allowance for doubtful accounts and certain other items.
−Removed: The revision for the year ended December 31, 2016, which consolidated financial statements are not included within this Annual Report on Form 10-K, resulted in an increase in revenue by $0.5 million and an increase in selling, general and administrative expense by $0.4 million, resulting in net loss being decreased by $0.1 million.
−Removed: The revision for the year ended December 31, 2017, which consolidated financial statements are not included within this Annual Report on Form 10-K, resulted in an increase in revenue by $0.6 million, increase in cost of revenue by $0.5 million, decrease in research and development expense by $0.1 million and an increase in selling, general and administrative expense by $0.5 million, resulting in net loss being decreased by $0.3 million.
−Removed: (2) Includes employee stock-based compensation as follows, which reflect revisions as described in (1) above:
−Removed: Year Ended December 31,
−Removed: 2020 2019 2018 2017 (1)
−Removed: Cost of revenue $ 27 $ 658 $ 193 $ 589 $ 25
−Removed: Research and development 7,727 4,462 3,057 1,619 271
−Removed: Selling, general and administrative 33,761 21,121 13,079 7,544 1,946
−Removed: Total stock-based compensation $ 41,515 $ 26,241 $ 16,329 $ 9,752 $ 2,242
−Removed: As of December 31,
−Removed: 2020 2019 2018 2017 (1)
−Removed: Consolidated Balance Sheets Data:
−Removed: Cash and cash equivalents $ 88,628 $ 20,462 $ 20,023 $ 8,671 $ 51,643
−Removed: Working capital 312,160 120,726 73,961 98,376 105,872
−Removed: Total assets 511,739 306,212 117,523 133,379 138,635
−Removed: Operating lease liabilities, noncurrent portion 81,293 85,748 — — —
−Removed: Notes payable 33,006 34,933 34,899 33,978 32,227
−Removed: Accumulated deficit (304,684) (260,393) (205,825) (156,801) (127,061)
−Removed: Total stockholders' equity $ 341,612 $ 135,409 $ 52,137 $ 79,341 $ 93,041
−Removed: (1) As disclosed in Note 1 to our consolidated financial statements included within this Annual Report on Form 10-K, we revised certain prior period financial information for immaterial errors in our accounting for revenues, contractual allowances, allowance for doubtful accounts and certain other items.
−Removed: The impact of the revision on our 2017 and 2016 consolidated balance sheets not included within this Annual Report on Form 10-K, was an decrease of $0.3 million and an increase of $0.5 million to working capital, an increase of $0.3 million and an increase of $0.5 million to total assets, an increase of $0.2 million and a decrease of $0.1 million to accumulated deficit and a decrease of $0.2 million and an increase of $0.5 million to stockholders’ equity as of December 31, 2017 and 2016, respectively.
+Added: Data responsive to Item 6 have not been presented in accordance with amendments to Item 301 of Regulation S-K.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.